| Dr Raymond Barrier Theodosis, MD | |
|
3575 Pecos Mcleod, Las Vegas, NV 89121-3803 | |
| (702) 731-2088 | |
| (702) 734-7836 |
| Full Name | Dr Raymond Barrier Theodosis |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 14 Years |
| Location | 3575 Pecos Mcleod, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730409566 | NPI | - | NPPES |
| 1730409566 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 15177 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shepherd Eye Center Ltd | 9234125907 | 37 |
News Archive
In the largest collaborative study of the brain to date, researchers from the Keck School of Medicine of the University of Southern California led a global consortium of 190 institutions to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer's disease, autism and other neurological conditions.
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time.
› Verified 9 days ago
| Entity Name | Shepherd Eye Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487604054 PECOS PAC ID: 9234125907 Enrollment ID: O20040420001820 |
News Archive
In the largest collaborative study of the brain to date, researchers from the Keck School of Medicine of the University of Southern California led a global consortium of 190 institutions to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer's disease, autism and other neurological conditions.
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond Barrier Theodosis, MD 3575 Pecos Mcleod, Las Vegas, NV 89121-3803 Ph: (702) 202-4776 | Dr Raymond Barrier Theodosis, MD 3575 Pecos Mcleod, Las Vegas, NV 89121-3803 Ph: (702) 731-2088 |
News Archive
In the largest collaborative study of the brain to date, researchers from the Keck School of Medicine of the University of Southern California led a global consortium of 190 institutions to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer's disease, autism and other neurological conditions.
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time.
› Verified 9 days ago
Dr. Jason Craig Wickens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 518, Las Vegas, NV 89144 Phone: 702-369-0200 Fax: 702-243-8383 | |
Dr. Surjeet Singh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 401, Las Vegas, NV 89106 Phone: 702-896-6043 Fax: 702-896-9591 | |
Peter Lloyd Hildebrand, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5005 | |
Dr. Brett D Brimhall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6850 N Durango Dr, 110, Las Vegas, NV 89149 Phone: 702-263-2020 Fax: 702-396-0287 | |
Helga F Pizio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5001 | |
Grace S Shin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6028 S Fort Apache Rd Ste 101, Las Vegas, NV 89148 Phone: 702-896-2020 Fax: 702-896-2025 | |
Dr. Jeffrey L. Hart, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5871 W. Craig Rd., Las Vegas, NV 89130 Phone: 702-724-2020 Fax: 702-724-2800 |